期刊文献+

人体血浆和垂体腺瘤组织中的神经肽Y含量及其临床意义 被引量:4

Research on Neuropeptide Y in Plasma and Tumor Tissue in Human Pituitary Adenomas
原文传递
导出
摘要 目的 :研究垂体腺瘤患者血浆和肿瘤组织中的神经肽Y(NPY)浓度与垂体腺瘤的关系。方法 :放射免疫分析方法测定 3 3例垂体腺瘤组织和 2 0例病人血浆的NPY浓度。结果 :不同类型垂体腺瘤组织中NPY含量有显著差别 ,侵袭性垂体腺瘤NPY含量高于非侵袭性垂体腺瘤。肿瘤组织与血浆NPY水平呈正相关。结论 :不同类型垂体腺瘤组织和血浆中NPY含量有显著差别 。 Aim:To investigate the plasma and tumor tissue neuropeptide Y (NPY) concentration in patients with pituitary adenoma in relation to tumor progression. Methods:Thirty three tumor tissues and twenty plasmas of NPY were measured by radioimmunoassay in the human pituitary adenomas. Results:There was a distinctive difference of the level of NPY in different type of pituitary tumor. The invasive group had a higher level of NPY than that of noninvasive group. The NPY level in pituitary tumor tissues has a positive relationship with that in plasma. Conclusion:There was a distinctive difference of the level of NPY in different types of pituitary tumor and plasma which can be taken as an indicator to evaluate the tumor invasive potential.
出处 《中国临床神经科学》 2001年第2期148-150,共3页 Chinese Journal of Clinical Neurosciences
关键词 垂体腺瘤 神经肽Y 放射免疫分析 侵袭性 pituitary adenoma neuropeptide Y radiommunoassay invasiveness
  • 引文网络
  • 相关文献

参考文献8

  • 1[1]Jones PM, Ghatei MA, Wallis SC, et al. Differential response ofneuropeptide Y, SP and VIP in the rat anterior pituitary gland to alterations inthyroid hormone status. J Endocrinol, 1994; 143: 393-397
  • 2[2]Byme JM, Jones PM, HIll SF, et al. Expression of messenger ribonucleicacids encoding neuropeptide-Y, substance-P, and vasoactive intestinalpolypeptide in human pituitary. J Clin endocrinol Metab, 1992; 75:983-987
  • 3[3]Adams EF, Venetikou Ms, Woods CA, et al. Neuropeptide Y directly inhibitsgrowth hormone secretion by human pituitary somatotropic tumours. ActaEndocrinol (Copenh), 1987; 115:149-154
  • 4[4]Watanobe H, Tamura T. Stimulation by neuropentide Y of growth hormonesecretion in prolactinoma in vivo. Neuropeptides, 1996; 30:429-432
  • 5[5]Watanobe H, Tamura T. Stimulatory and inhibitory effects of neuropeptide Yon growth hormone secretion in acromegaly in vivo. Neuropeptides, 1997;31:29-34
  • 6[6]Grouzmann E, Deruaz JP, Gomez F, et al. lmmunolocalization ofneuropeptide Y in human pituitay tumours. Regul Pept, 1998; 25(75-76):89-92
  • 7[7]Chabot JG, Enjalbert A, Pelletier G, et al. Evidence for a direct action ofneuropeptide Y in the rat pituitary gland. Neuroendocrinology, 1988; 47:511-517
  • 8[8]Allen JM, Yeats JC, Causon R, et al. Neuropeptide and its flanking peptidein human endocrine tumors and plasma. J Clin Endocrin Metab, 1987; 64:1199-1204

同被引文献21

  • 1傅小锁,张景艳.神经肽Y及其作用[J].生理科学进展,1993,24(2):152-155. 被引量:50
  • 2成蓓,张银环,吴剑萍,段家华.冠心病患者血浆神经肽Y水平的临床观察[J].临床心血管病杂志,1995,11(2):73-75. 被引量:10
  • 3曾春雨.神经肽Y在心血管系统中的作用[J].心血管病学进展,1997,18(3):164-167. 被引量:28
  • 4Blakemore LJ,Levenson CW,Trombley PO.Neuropetide Y modulates excitatory synaptic transmission in the olfactory bulb Neuroseience.2006,138(2):663 -674.
  • 5郭长利 马景镒.人体血浆和垂体肿瘤组织神经肽Y含量及其mRNA表达[J].河北医药,2000,22:14-14.
  • 6Peng XD, Park S, Gadelha MR, et al. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice:hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback. Endocrinology,2001. 142: 1117-1123.
  • 7Tamas LH, Shuye P, Michael GD, et al. A GABA-neuropeptide y (NPY) in LH release. Peptides, 2001, 22: 473-481.
  • 8Sainsbury A, Herzog H. Inhibitory effects of central neuropeptde y on the somatotropic and gonadotropic axes in male rates are independent of adrenal hormones. Peptides, 2001, 22: 467-471.
  • 9Fekete C, Kelly J, Mihaly E, et al. Neuropeptide y has a central inihbitory action on the hypothalamic-pituitary-thyroid axis. Endocrinology, 2001, 142: 2606-2613.
  • 10Nillni EA, Vaslet C, Harris M, et al. Leptin regulates prothyrotropin-releasing hormone biosynthesis.direct and indirect pathways. J Biol Chem, 2000,36133.Evidence for 275: 36124-36133.

引证文献4

二级引证文献10

;
使用帮助 返回顶部